NASDAQ:MDRX

Allscripts Healthcare Solutions - MDRX Stock Forecast, Price & News

$18.75

+0.42 (+2.29%)

(As of 12/8/2022 12:00 AM ET)

Add

Compare

Today's Range: $18.30
▼
$18.80
50-Day Range: $13.85
▼
$19.06
52-Week Range: $13.59
▼
$23.25

Volume: 1.26 million shs
Average Volume: 1.57 million shs
Market Capitalization: $2.05 billion

P/E Ratio: 43.60
Dividend Yield: N/A
Price Target: $22.67

Allscripts Healthcare Solutions MarketRank™ Forecast

Analyst Rating: Moderate Buy
2.57 Rating Score
Upside/Downside: 20.9% Upside
$22.67 Price Target
Short Interest: Bearish
9.26% of Float Sold Short
Dividend Strength: N/A
Sustainability: -0.62
Upright™ Environmental Score
News Sentiment: 0.81
Based on 8 Articles This Week
Insider Trading: Selling Shares
$1.09 M Sold Last Quarter
Proj. Earnings Growth: 15.38%
From $0.65 to $0.75 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.70 out of 5 stars

Medical Sector

69th out of 1,022 stocks

Computer Integrated Systems Design Industry

4th out of 37 stocks

3.3

Analyst's Opinion

Consensus Rating
Allscripts Healthcare Solutions has received a consensus rating of Buy. The company's average rating score is 2.57, and is based on 5 buy ratings, 1 hold rating, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $22.67, Allscripts Healthcare Solutions has a forecasted upside of 20.9% from its current price of $18.75.
Amount of Analyst Coverage
Allscripts Healthcare Solutions has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.0

Short Interest

Percentage of Shares Shorted
9.26% of the float of Allscripts Healthcare Solutions has been sold short.
Short Interest Ratio / Days to Cover
Allscripts Healthcare Solutions has a short interest ratio ("days to cover") of 7.5.
Change versus previous month
Short interest in Allscripts Healthcare Solutions has recently increased by 1.87%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
Allscripts Healthcare Solutions does not currently pay a dividend.
Dividend Growth
Allscripts Healthcare Solutions does not have a long track record of dividend growth.

4.1

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Allscripts Healthcare Solutions has received a 59.51% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Computerized clinical decision support software", "Personal health record software", and "Documentation software for clinicians" products. See details.
Environmental Sustainability
The Environmental Impact score for Allscripts Healthcare Solutions is -0.62.

3.2

News and Social Media Coverage

News Sentiment
Allscripts Healthcare Solutions has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 8 news articles for Allscripts Healthcare Solutions this week, compared to 2 articles on an average week.
Search Interest
Only 1 people have searched for MDRX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
MarketBeat Follows
4 people have added Allscripts Healthcare Solutions to their MarketBeat watchlist in the last 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Allscripts Healthcare Solutions insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,094,425.00 in company stock.
Percentage Held by Insiders
Only 2.29% of the stock of Allscripts Healthcare Solutions is held by insiders.
Percentage Held by Institutions
99.76% of the stock of Allscripts Healthcare Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Allscripts Healthcare Solutions are expected to grow by 15.38% in the coming year, from $0.65 to $0.75 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Allscripts Healthcare Solutions is 43.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 126.30.
Price to Earnings Ratio vs. Sector
The P/E ratio of Allscripts Healthcare Solutions is 43.60, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 128.44.
Price to Earnings Growth Ratio
Allscripts Healthcare Solutions has a PEG Ratio of 1.74. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Allscripts Healthcare Solutions has a P/B Ratio of 1.63. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Allscripts Healthcare Solutions (NASDAQ:MDRX) Stock

Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates through two segments, Hospitals and Large Physician Practices, and Veradigm. The Hospitals and Large Physician Practices segment provides integrated clinical and financial management solutions, which primarily include EHR-related software; and related installation, support and maintenance, outsourcing, private cloud hosting, and revenue cycle management services. The Veradigm segment offers payer and life sciences solutions, which are primarily targeted at payers, life sciences companies, and other healthcare stakeholders; and software applications for patient engagement and EHR software to single-specialty, and small and mid-sized physician practices, including related clinical, financial, administrative, and operational solutions. Its solutions enable clients to transition, analyze, and coordinate care, and enhance the healthcare delivery across the care community. The company serves physicians, hospitals, governments and militaries, health systems, health plans, life-sciences companies, retail clinics, surgery centers, retail pharmacies, pharmacy benefit managers, insurance companies, employer wellness clinics, consumers, lab companies, urgent care facilities, and venture capital firms, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allscripts Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.

MDRX Stock News Headlines

December 8, 2022 | americanbankingnews.com

Allscripts Healthcare Solutions (NASDAQ:MDRX) Upgraded by Argus to Buy

December 2, 2022 | markets.businessinsider.com

SVB Securities Reaffirms Their Buy Rating on Allscripts (MDRX)

November 30, 2022 | finance.yahoo.com

Sphere's TrustCommerce® Healthcare Payments Platform Now Integrated with Veradigm® Practice Management

November 28, 2022 | americanbankingnews.com

Analyzing Aspyra (OTCMKTS:APYI) & Allscripts Healthcare Solutions (NASDAQ:MDRX)

November 27, 2022 | finance.yahoo.com

Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

November 22, 2022 | finance.yahoo.com

Veradigm Digital Health Media Becomes the First EHR Marketing Solution to Join the Point of Care Marketing Association

November 9, 2022 | finance.yahoo.com

Veradigm EHR Achieves 2015 ONC Health IT Update Certification

November 5, 2022 | seekingalpha.com

Allscripts Healthcare Solutions, Inc. (MDRX) Q3 2022 Earnings Call Transcript

November 4, 2022 | finance.yahoo.com

AllScripts Healthcare (MDRX) Q3 Earnings Top Estimates

November 3, 2022 | finance.yahoo.com

Allscripts Healthcare Solutions, Inc.'s (NASDAQ:MDRX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

November 3, 2022 | finance.yahoo.com

Allscripts announces third quarter of 2022 results

October 20, 2022 | finance.yahoo.com

Allscripts to release third-quarter 2022 financial results November 3

October 13, 2022 | finance.yahoo.com

Allscripts Healthcare Solutions, Inc. (MDRX)

October 11, 2022 | finance.yahoo.com

Even though Allscripts Healthcare Solutions (NASDAQ:MDRX) has lost US$130m market cap in last 7 days, shareholders are still up 38% over 3 years

September 19, 2022 | finance.yahoo.com

Allscripts to Host Virtual Investor Day September 28th

September 14, 2022 | finance.yahoo.com

Veradigm and Vytalize Health: Paving the Way for Primary Care Physicians to Improve Patient Outcomes

September 7, 2022 | finance.yahoo.com

Here's Why You Should Hold on to Allscripts (MDRX) Stock Now

September 6, 2022 | finance.yahoo.com

Veradigm Payerpath Ranks First in End-To-End Revenue Cycle Management (RCM) Software Technology from Black Book™ Research

August 29, 2022 | finance.yahoo.com

Veradigm Payerpath Ranked as #1 Solution for 2022 by Black Book

August 26, 2022 | thestreet.com

Water-Logged And Getting Wetter: Allscripts Healthcare Solutions (MDRX)

August 23, 2022 | nasdaq.com

Investors in Allscripts Healthcare Solutions (NASDAQ:MDRX) have made a notable return of 82% over the past three years

August 22, 2022 | finance.yahoo.com

Is It Too Late To Consider Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

August 9, 2022 | finance.yahoo.com

Can AllScripts (MDRX) Climb 27% to Reach the Level Wall Street Analysts Expect?

August 9, 2022 | finance.yahoo.com

MDRX vs. OMCL: Which Stock Should Value Investors Buy Now?

August 8, 2022 | finance.yahoo.com

Allscripts (MDRX) Q2 Earnings & Revenues Surpass Estimates

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allscripts Healthcare Solutions and its competitors with MarketBeat's FREE daily newsletter.

MDRX Company Calendar

Last Earnings: 11/03/2022
Today: 12/08/2022
Fiscal Year End: 12/31/2022
Next Earnings (Estimated): 2/23/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Computer integrated systems design
Sub-Industry: Health Care Technology
Sector: Medical
Current Symbol: NASDAQ:MDRX
CUSIP: 01988P10
CIK: 1124804
Web: www.allscripts.com
Phone: (800) 334-8534
Fax: 313-322-9600
Employees: 8,000
Year Founded: 1986

Price Target and Rating

Average Stock Price Forecast: $22.67
High Stock Price Forecast: $26.00
Low Stock Price Forecast: $17.00
Forecasted Upside/Downside: +20.9%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.57
Research Coverage: 7 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.43
Trailing P/E Ratio: 43.60
Forward P/E Ratio: 28.85
P/E Growth: 1.74
Net Income: $134.44 million
Net Margins: 7.25%
Pretax Margin: 14.59%
Return on Equity: 10.74%
Return on Assets: 6.68%

Debt

Debt-to-Equity Ratio: 0.17
Current Ratio: 3.20
Quick Ratio: 3.20

Sales & Book Value

Annual Sales: $1.50 billion
Price / Sales: 1.36
Cash Flow: $2.79 per share
Price / Cash Flow: 6.72
Book Value: $11.49 per share
Price / Book: 1.63

Miscellaneous

Outstanding Shares: 109,260,000
Free Float: 106,758,000
Market Cap: $2.05 billion
Optionable: Optionable
Beta: 1.01

Social Links

Key Executives

Mr. Richard J. Poulton (Age 57)
CEO & Director
Comp: $2.45M

Ms. Tejal Vakharia (Age 49)
Sr. VP of Marketing & Gov. Affairs, Gen. Counsel and Chief Compliance Counsel
Comp: $1.04M

Mr. Thomas J. Langan (Age 56)
Pres & CCO

Ms. Leah Jones (Age 50)
Chief Financial Officer

Mr. Joseph R. Rostock (Age 59)
Sr. VP of Devel. & CTO

Jenny Gelinas
VP of Investor Relations

Mr. Richard Elmore
Sr. VP of Corp. Devel. & Strategy

Ms. Rebecca Whaley
VP of Marketing

Ms. Lisa Hammond C.P.C. (Age 50)
Sr. VP & Chief HR Officer

Mr. Paul Lewis
Sr. VP of Sales & Services and Acting Gen. Mang.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MDRX Stock - Frequently Asked Questions

Should I buy or sell Allscripts Healthcare Solutions stock right now?: 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MDRX shares.
View MDRX analyst ratings or view top-rated stocks.
What is Allscripts Healthcare Solutions' stock price forecast for 2023?: 7 analysts have issued twelve-month price objectives for Allscripts Healthcare Solutions' stock. Their MDRX share price forecasts range from $17.00 to $26.00. On average, they anticipate the company's stock price to reach $22.67 in the next year. This suggests a possible upside of 20.9% from the stock's current price.
View analysts price targets for MDRX or view top-rated stocks among Wall Street analysts.
How have MDRX shares performed in 2022?: Allscripts Healthcare Solutions' stock was trading at $18.45 at the beginning of 2022. Since then, MDRX stock has increased by 1.6% and is now trading at $18.75.
View the best growth stocks for 2022 here.
When is Allscripts Healthcare Solutions' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our MDRX earnings forecast.
How were Allscripts Healthcare Solutions' earnings last quarter?: Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) announced its quarterly earnings results on Thursday, November, 3rd. The software maker reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.04. The software maker had revenue of $151.90 million for the quarter, compared to the consensus estimate of $152.79 million. Allscripts Healthcare Solutions had a net margin of 7.25% and a trailing twelve-month return on equity of 10.74%. Allscripts Healthcare Solutions's revenue for the quarter was up 5.0% on a year-over-year basis. During the same period last year, the company posted $0.21 EPS.
How will Allscripts Healthcare Solutions' stock buyback program work?: Allscripts Healthcare Solutions announced that its board has authorized a share buyback plan on Wednesday, May 26th 2021, which permits the company to buyback $350,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire up to 14% of its shares through open market purchases. Shares buyback plans are often an indication that the company's management believes its shares are undervalued.
What is Paul Black's approval rating as Allscripts Healthcare Solutions' CEO?: 796 employees have rated Allscripts Healthcare Solutions Chief Executive Officer Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Allscripts Healthcare Solutions own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).
What is Allscripts Healthcare Solutions' stock symbol?: Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."
Who are Allscripts Healthcare Solutions' major shareholders?: Allscripts Healthcare Solutions' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (19.06%), Vanguard Group Inc. (12.40%), Dimensional Fund Advisors LP (8.36%), Fisher Asset Management LLC (4.86%), State Street Corp (3.80%) and Jacobs Levy Equity Management Inc. (1.46%). Insiders that own company stock include Brian Farley, David B Stevens, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Leah Jones, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton and Thomas Langan.
View institutional ownership trends.
How do I buy shares of Allscripts Healthcare Solutions?: Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Allscripts Healthcare Solutions' stock price today?: One share of MDRX stock can currently be purchased for approximately $18.75.
How much money does Allscripts Healthcare Solutions make?: Allscripts Healthcare Solutions (NASDAQ:MDRX) has a market capitalization of $2.05 billion and generates $1.50 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $0.43 on an earnings per share basis.
How many employees does Allscripts Healthcare Solutions have?: The company employs 8,000 workers across the globe.
Does Allscripts Healthcare Solutions have any subsidiaries?: The following companies are subsidiares of Allscripts Healthcare Solutions: HealthGrid, Practice Fusion, and ZappRx.
Read More
How can I contact Allscripts Healthcare Solutions?: Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The official website for the company is www.allscripts.com. The software maker can be reached via phone at (800) 334-8534, via email at stephen.shulstein@allscripts.com, or via fax at 313-322-9600.

This page (NASDAQ:MDRX) was last updated on 12/8/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial